nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—Ibuprofen—CXCL8—pancreatic cancer	0.00443	0.379	CrCbGaD
Baclofen—Ibuprofen—PPARG—pancreatic cancer	0.00306	0.262	CrCbGaD
Baclofen—Chlorphenesin—PTGS2—pancreatic cancer	0.0029	0.248	CrCbGaD
Baclofen—GABBR1—GPCR ligand binding—CCKAR—pancreatic cancer	0.00139	0.00498	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—SCT—pancreatic cancer	0.00133	0.00478	CbGpPWpGaD
Baclofen—Ibuprofen—PTGS2—pancreatic cancer	0.00129	0.111	CrCbGaD
Baclofen—GABBR2—Signaling by GPCR—GAST—pancreatic cancer	0.00128	0.00458	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CCK—pancreatic cancer	0.00127	0.00456	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—SHH—pancreatic cancer	0.00127	0.00454	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PRLHR—pancreatic cancer	0.00126	0.00453	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—IAPP—pancreatic cancer	0.00125	0.00449	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00124	0.00445	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CNR2—pancreatic cancer	0.00124	0.00444	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—GLP1R—pancreatic cancer	0.00124	0.00444	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CCKAR—pancreatic cancer	0.00122	0.00437	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—SCT—pancreatic cancer	0.00121	0.00434	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—PTHLH—pancreatic cancer	0.0012	0.00431	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—PTCH1—pancreatic cancer	0.0012	0.00431	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—SSTR3—pancreatic cancer	0.00118	0.00424	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PRLHR—pancreatic cancer	0.00116	0.00415	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GDI1—pancreatic cancer	0.00116	0.00415	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GDI2—pancreatic cancer	0.00116	0.00415	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CCK—pancreatic cancer	0.00115	0.00414	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—SSTR1—pancreatic cancer	0.00113	0.00406	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CNR2—pancreatic cancer	0.00112	0.00403	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—GLP1R—pancreatic cancer	0.00112	0.00403	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PPY—pancreatic cancer	0.00111	0.00398	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CCKAR—pancreatic cancer	0.00111	0.00397	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—SST—pancreatic cancer	0.0011	0.00394	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—IAPP—pancreatic cancer	0.0011	0.00394	CbGpPWpGaD
Baclofen—GABBR2—G alpha (i) signalling events—CXCL8—pancreatic cancer	0.0011	0.00393	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—SSTR2—pancreatic cancer	0.00109	0.00391	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ZNRF3—pancreatic cancer	0.00109	0.0039	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ACVR1B—pancreatic cancer	0.00109	0.0039	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—SSTR3—pancreatic cancer	0.00107	0.00385	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PTHLH—pancreatic cancer	0.00105	0.00378	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CCKBR—pancreatic cancer	0.00105	0.00378	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—SSTR1—pancreatic cancer	0.00103	0.00369	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CNR1—pancreatic cancer	0.00101	0.00364	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—SHH—pancreatic cancer	0.00101	0.00362	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PPY—pancreatic cancer	0.00101	0.00362	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IAPP—pancreatic cancer	0.000996	0.00357	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—SSTR2—pancreatic cancer	0.00099	0.00355	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SSTR3—pancreatic cancer	0.000984	0.00353	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—DTX1—pancreatic cancer	0.000984	0.00353	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—GCG—pancreatic cancer	0.000979	0.00351	CbGpPWpGaD
Baclofen—GABBR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000974	0.00349	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—SST—pancreatic cancer	0.000963	0.00345	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PTHLH—pancreatic cancer	0.000956	0.00343	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PTCH1—pancreatic cancer	0.000956	0.00343	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CCKBR—pancreatic cancer	0.000956	0.00343	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SSTR1—pancreatic cancer	0.000943	0.00338	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—AGTR1—pancreatic cancer	0.000934	0.00335	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PPY—pancreatic cancer	0.000925	0.00332	CbGpPWpGaD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000922	0.00331	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SSTR2—pancreatic cancer	0.000908	0.00326	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—GAST—pancreatic cancer	0.000906	0.00325	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CNR1—pancreatic cancer	0.000889	0.00319	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CCKBR—pancreatic cancer	0.000877	0.00314	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—SST—pancreatic cancer	0.000875	0.00314	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—GCG—pancreatic cancer	0.000859	0.00308	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—SCT—pancreatic cancer	0.000859	0.00308	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GLI1—pancreatic cancer	0.000824	0.00296	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—DTX4—pancreatic cancer	0.000824	0.00296	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—GAST—pancreatic cancer	0.000822	0.00295	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CCK—pancreatic cancer	0.000819	0.00294	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000819	0.00294	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CNR1—pancreatic cancer	0.000807	0.0029	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NRP1—pancreatic cancer	0.000802	0.00288	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000802	0.00288	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CNR2—pancreatic cancer	0.000798	0.00286	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000798	0.00286	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000785	0.00282	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—GCG—pancreatic cancer	0.00078	0.0028	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—SCT—pancreatic cancer	0.00078	0.0028	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HEY2—pancreatic cancer	0.000772	0.00277	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GAST—pancreatic cancer	0.000754	0.0027	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PRLHR—pancreatic cancer	0.000746	0.00267	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—AGTR1—pancreatic cancer	0.000744	0.00267	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CCK—pancreatic cancer	0.000744	0.00267	CbGpPWpGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000732	0.00263	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CNR2—pancreatic cancer	0.000725	0.0026	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—GLP1R—pancreatic cancer	0.000725	0.0026	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SCT—pancreatic cancer	0.000715	0.00256	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HEY1—pancreatic cancer	0.000715	0.00256	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CCKAR—pancreatic cancer	0.000713	0.00256	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—IAPP—pancreatic cancer	0.000707	0.00254	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—CXCL8—pancreatic cancer	0.000707	0.00253	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ZNRF3—pancreatic cancer	0.000701	0.00251	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ACVR1B—pancreatic cancer	0.000701	0.00251	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CCK—pancreatic cancer	0.000682	0.00245	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000679	0.00243	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CNR2—pancreatic cancer	0.000664	0.00238	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GLP1R—pancreatic cancer	0.000664	0.00238	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—CXCL8—pancreatic cancer	0.000664	0.00238	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CCKAR—pancreatic cancer	0.000654	0.00234	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—SHH—pancreatic cancer	0.00065	0.00233	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IAPP—pancreatic cancer	0.000642	0.0023	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—JAG2—pancreatic cancer	0.000634	0.00227	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SSTR3—pancreatic cancer	0.000634	0.00227	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—DTX1—pancreatic cancer	0.000634	0.00227	CbGpPWpGaD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000628	0.00225	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MEN1—pancreatic cancer	0.000625	0.00224	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—SST—pancreatic cancer	0.000621	0.00223	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PTHLH—pancreatic cancer	0.000616	0.00221	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PTCH1—pancreatic cancer	0.000616	0.00221	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SSTR1—pancreatic cancer	0.000608	0.00218	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PPY—pancreatic cancer	0.000596	0.00214	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SHH—pancreatic cancer	0.000596	0.00214	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NOTCH4—pancreatic cancer	0.000592	0.00212	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IAPP—pancreatic cancer	0.000589	0.00211	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SSTR2—pancreatic cancer	0.000585	0.0021	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CNR1—pancreatic cancer	0.000573	0.00205	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PTHLH—pancreatic cancer	0.000565	0.00203	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PTCH1—pancreatic cancer	0.000565	0.00203	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCKBR—pancreatic cancer	0.000565	0.00203	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—SST—pancreatic cancer	0.000564	0.00202	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—HRAS—pancreatic cancer	0.000561	0.00201	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—GCG—pancreatic cancer	0.000553	0.00198	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—DTX4—pancreatic cancer	0.000531	0.00191	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GLI1—pancreatic cancer	0.000531	0.00191	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000528	0.00189	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CNR1—pancreatic cancer	0.00052	0.00187	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000517	0.00185	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NRP1—pancreatic cancer	0.000517	0.00185	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SST—pancreatic cancer	0.000517	0.00185	CbGpPWpGaD
Baclofen—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000512	0.000722	CcSEcCtD
Baclofen—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000511	0.000721	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.00051	0.00183	CbGpPWpGaD
Baclofen—Anaemia—Docetaxel—pancreatic cancer	0.000507	0.000715	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—JAG1—pancreatic cancer	0.000506	0.00181	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NOTCH3—pancreatic cancer	0.000504	0.00181	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—GCG—pancreatic cancer	0.000502	0.0018	CbGpPWpGaD
Baclofen—Muscular weakness—Doxorubicin—pancreatic cancer	0.000502	0.000707	CcSEcCtD
Baclofen—Vomiting—Sunitinib—pancreatic cancer	0.0005	0.000705	CcSEcCtD
Baclofen—Body temperature increased—Gemcitabine—pancreatic cancer	0.000499	0.000703	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—HEY2—pancreatic cancer	0.000497	0.00178	CbGpPWpGaD
Baclofen—Dysuria—Epirubicin—pancreatic cancer	0.000497	0.0007	CcSEcCtD
Baclofen—Rash—Sunitinib—pancreatic cancer	0.000496	0.000699	CcSEcCtD
Baclofen—Dermatitis—Sunitinib—pancreatic cancer	0.000496	0.000698	CcSEcCtD
Baclofen—Urticaria—Fluorouracil—pancreatic cancer	0.000493	0.000695	CcSEcCtD
Baclofen—Headache—Sunitinib—pancreatic cancer	0.000493	0.000695	CcSEcCtD
Baclofen—Syncope—Docetaxel—pancreatic cancer	0.000492	0.000694	CcSEcCtD
Baclofen—Influenza—Doxorubicin—pancreatic cancer	0.000492	0.000693	CcSEcCtD
Baclofen—Dysphagia—Doxorubicin—pancreatic cancer	0.000492	0.000693	CcSEcCtD
Baclofen—Pollakiuria—Epirubicin—pancreatic cancer	0.000491	0.000692	CcSEcCtD
Baclofen—Body temperature increased—Fluorouracil—pancreatic cancer	0.000491	0.000691	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—GAST—pancreatic cancer	0.000486	0.00174	CbGpPWpGaD
Baclofen—Palpitations—Docetaxel—pancreatic cancer	0.000485	0.000684	CcSEcCtD
Baclofen—Weight increased—Epirubicin—pancreatic cancer	0.000483	0.000681	CcSEcCtD
Baclofen—Loss of consciousness—Docetaxel—pancreatic cancer	0.000482	0.00068	CcSEcCtD
Baclofen—Weight decreased—Epirubicin—pancreatic cancer	0.000481	0.000677	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000479	0.00172	CbGpPWpGaD
Baclofen—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000479	0.000675	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CNR1—pancreatic cancer	0.000477	0.00171	CbGpPWpGaD
Baclofen—Pneumonia—Epirubicin—pancreatic cancer	0.000476	0.000672	CcSEcCtD
Baclofen—Convulsion—Docetaxel—pancreatic cancer	0.000476	0.00067	CcSEcCtD
Baclofen—Hypertension—Docetaxel—pancreatic cancer	0.000474	0.000668	CcSEcCtD
Baclofen—Drowsiness—Epirubicin—pancreatic cancer	0.000474	0.000668	CcSEcCtD
Baclofen—GABBR1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000472	0.00169	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000469	0.00168	CbGpPWpGaD
Baclofen—Chest pain—Docetaxel—pancreatic cancer	0.000467	0.000659	CcSEcCtD
Baclofen—Myalgia—Docetaxel—pancreatic cancer	0.000467	0.000659	CcSEcCtD
Baclofen—Nausea—Sunitinib—pancreatic cancer	0.000467	0.000659	CcSEcCtD
Baclofen—Renal failure—Epirubicin—pancreatic cancer	0.000466	0.000656	CcSEcCtD
Baclofen—Asthenia—Irinotecan—pancreatic cancer	0.000465	0.000655	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000464	0.000654	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000463	0.00166	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GCG—pancreatic cancer	0.000461	0.00165	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SCT—pancreatic cancer	0.000461	0.00165	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HEY1—pancreatic cancer	0.000461	0.00165	CbGpPWpGaD
Baclofen—Dysuria—Doxorubicin—pancreatic cancer	0.00046	0.000648	CcSEcCtD
Baclofen—Dry mouth—Docetaxel—pancreatic cancer	0.000457	0.000644	CcSEcCtD
Baclofen—Sweating—Epirubicin—pancreatic cancer	0.000454	0.00064	CcSEcCtD
Baclofen—Pollakiuria—Doxorubicin—pancreatic cancer	0.000454	0.00064	CcSEcCtD
Baclofen—Asthenia—Gemcitabine—pancreatic cancer	0.000453	0.000638	CcSEcCtD
Baclofen—Haematuria—Epirubicin—pancreatic cancer	0.000452	0.000637	CcSEcCtD
Baclofen—Confusional state—Docetaxel—pancreatic cancer	0.000452	0.000637	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000448	0.00161	CbGpPWpGaD
Baclofen—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000448	0.000631	CcSEcCtD
Baclofen—Oedema—Docetaxel—pancreatic cancer	0.000448	0.000631	CcSEcCtD
Baclofen—Weight increased—Doxorubicin—pancreatic cancer	0.000447	0.000631	CcSEcCtD
Baclofen—Pruritus—Gemcitabine—pancreatic cancer	0.000447	0.000629	CcSEcCtD
Baclofen—Infection—Docetaxel—pancreatic cancer	0.000445	0.000627	CcSEcCtD
Baclofen—Weight decreased—Doxorubicin—pancreatic cancer	0.000445	0.000627	CcSEcCtD
Baclofen—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000443	0.000625	CcSEcCtD
Baclofen—Diarrhoea—Irinotecan—pancreatic cancer	0.000443	0.000625	CcSEcCtD
Baclofen—Pneumonia—Doxorubicin—pancreatic cancer	0.000441	0.000621	CcSEcCtD
Baclofen—Shock—Docetaxel—pancreatic cancer	0.000441	0.000621	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—AGTR1—pancreatic cancer	0.000439	0.00158	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCK—pancreatic cancer	0.000439	0.00158	CbGpPWpGaD
Baclofen—Nervous system disorder—Docetaxel—pancreatic cancer	0.000439	0.000619	CcSEcCtD
Baclofen—Pruritus—Fluorouracil—pancreatic cancer	0.000439	0.000619	CcSEcCtD
Baclofen—Drowsiness—Doxorubicin—pancreatic cancer	0.000438	0.000618	CcSEcCtD
Baclofen—Tachycardia—Docetaxel—pancreatic cancer	0.000437	0.000616	CcSEcCtD
Baclofen—Skin disorder—Docetaxel—pancreatic cancer	0.000435	0.000613	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—STK11—pancreatic cancer	0.000433	0.00155	CbGpPWpGaD
Baclofen—Bradycardia—Epirubicin—pancreatic cancer	0.000433	0.00061	CcSEcCtD
Baclofen—Diarrhoea—Gemcitabine—pancreatic cancer	0.000432	0.000609	CcSEcCtD
Baclofen—Renal failure—Doxorubicin—pancreatic cancer	0.000431	0.000607	CcSEcCtD
Baclofen—Dizziness—Irinotecan—pancreatic cancer	0.000428	0.000604	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CNR2—pancreatic cancer	0.000428	0.00154	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GLP1R—pancreatic cancer	0.000428	0.00154	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000428	0.00153	CbGpPWpGaD
Baclofen—Anorexia—Docetaxel—pancreatic cancer	0.000427	0.000602	CcSEcCtD
Baclofen—Rhinitis—Epirubicin—pancreatic cancer	0.000426	0.000601	CcSEcCtD
Baclofen—Diarrhoea—Fluorouracil—pancreatic cancer	0.000425	0.000598	CcSEcCtD
Baclofen—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000423	0.000596	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CCKAR—pancreatic cancer	0.000421	0.00151	CbGpPWpGaD
Baclofen—Sweating—Doxorubicin—pancreatic cancer	0.00042	0.000592	CcSEcCtD
Baclofen—Urinary tract disorder—Epirubicin—pancreatic cancer	0.00042	0.000592	CcSEcCtD
Baclofen—Oedema peripheral—Epirubicin—pancreatic cancer	0.000419	0.00059	CcSEcCtD
Baclofen—Hypotension—Docetaxel—pancreatic cancer	0.000419	0.00059	CcSEcCtD
Baclofen—Haematuria—Doxorubicin—pancreatic cancer	0.000418	0.000589	CcSEcCtD
Baclofen—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000418	0.000589	CcSEcCtD
Baclofen—Urethral disorder—Epirubicin—pancreatic cancer	0.000417	0.000588	CcSEcCtD
Baclofen—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000415	0.000584	CcSEcCtD
Baclofen—Vomiting—Irinotecan—pancreatic cancer	0.000412	0.000581	CcSEcCtD
Baclofen—Dizziness—Fluorouracil—pancreatic cancer	0.00041	0.000578	CcSEcCtD
Baclofen—Visual impairment—Epirubicin—pancreatic cancer	0.00041	0.000578	CcSEcCtD
Baclofen—Rash—Irinotecan—pancreatic cancer	0.000409	0.000576	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—JAG2—pancreatic cancer	0.000408	0.00147	CbGpPWpGaD
Baclofen—Dermatitis—Irinotecan—pancreatic cancer	0.000408	0.000575	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000408	0.000575	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000407	0.00146	CbGpPWpGaD
Baclofen—Headache—Irinotecan—pancreatic cancer	0.000406	0.000572	CcSEcCtD
Baclofen—Insomnia—Docetaxel—pancreatic cancer	0.000405	0.000571	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—MEN1—pancreatic cancer	0.000403	0.00144	CbGpPWpGaD
Baclofen—Paraesthesia—Docetaxel—pancreatic cancer	0.000402	0.000567	CcSEcCtD
Baclofen—Vomiting—Gemcitabine—pancreatic cancer	0.000401	0.000566	CcSEcCtD
Baclofen—Bradycardia—Doxorubicin—pancreatic cancer	0.000401	0.000565	CcSEcCtD
Baclofen—Dyspnoea—Docetaxel—pancreatic cancer	0.000399	0.000563	CcSEcCtD
Baclofen—Somnolence—Docetaxel—pancreatic cancer	0.000398	0.000561	CcSEcCtD
Baclofen—Rash—Gemcitabine—pancreatic cancer	0.000398	0.000561	CcSEcCtD
Baclofen—Dermatitis—Gemcitabine—pancreatic cancer	0.000398	0.00056	CcSEcCtD
Baclofen—Eye disorder—Epirubicin—pancreatic cancer	0.000397	0.00056	CcSEcCtD
Baclofen—Tinnitus—Epirubicin—pancreatic cancer	0.000396	0.000559	CcSEcCtD
Baclofen—Headache—Gemcitabine—pancreatic cancer	0.000395	0.000557	CcSEcCtD
Baclofen—Flushing—Epirubicin—pancreatic cancer	0.000395	0.000556	CcSEcCtD
Baclofen—Cardiac disorder—Epirubicin—pancreatic cancer	0.000395	0.000556	CcSEcCtD
Baclofen—Vomiting—Fluorouracil—pancreatic cancer	0.000395	0.000556	CcSEcCtD
Baclofen—Rhinitis—Doxorubicin—pancreatic cancer	0.000394	0.000556	CcSEcCtD
Baclofen—Dyspepsia—Docetaxel—pancreatic cancer	0.000394	0.000556	CcSEcCtD
Baclofen—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000391	0.000552	CcSEcCtD
Baclofen—Rash—Fluorouracil—pancreatic cancer	0.000391	0.000551	CcSEcCtD
Baclofen—Dermatitis—Fluorouracil—pancreatic cancer	0.000391	0.000551	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000391	0.0014	CbGpPWpGaD
Baclofen—Decreased appetite—Docetaxel—pancreatic cancer	0.000389	0.000549	CcSEcCtD
Baclofen—Headache—Fluorouracil—pancreatic cancer	0.000389	0.000548	CcSEcCtD
Baclofen—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000389	0.000548	CcSEcCtD
Baclofen—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000388	0.000546	CcSEcCtD
Baclofen—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000387	0.000545	CcSEcCtD
Baclofen—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000387	0.000545	CcSEcCtD
Baclofen—Fatigue—Docetaxel—pancreatic cancer	0.000386	0.000544	CcSEcCtD
Baclofen—Angiopathy—Epirubicin—pancreatic cancer	0.000386	0.000544	CcSEcCtD
Baclofen—Urethral disorder—Doxorubicin—pancreatic cancer	0.000386	0.000544	CcSEcCtD
Baclofen—Nausea—Irinotecan—pancreatic cancer	0.000385	0.000542	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—SHH—pancreatic cancer	0.000384	0.00138	CbGpPWpGaD
Baclofen—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000383	0.00054	CcSEcCtD
Baclofen—Pain—Docetaxel—pancreatic cancer	0.000383	0.00054	CcSEcCtD
Baclofen—Constipation—Docetaxel—pancreatic cancer	0.000383	0.00054	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000382	0.00137	CbGpPWpGaD
Baclofen—Chills—Epirubicin—pancreatic cancer	0.000382	0.000538	CcSEcCtD
Baclofen—Arrhythmia—Epirubicin—pancreatic cancer	0.00038	0.000535	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—SMAD4—pancreatic cancer	0.000379	0.00136	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IAPP—pancreatic cancer	0.000379	0.00136	CbGpPWpGaD
Baclofen—Visual impairment—Doxorubicin—pancreatic cancer	0.000379	0.000534	CcSEcCtD
Baclofen—Alopecia—Epirubicin—pancreatic cancer	0.000376	0.00053	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000375	0.00135	CbGpPWpGaD
Baclofen—Nausea—Gemcitabine—pancreatic cancer	0.000375	0.000528	CcSEcCtD
Baclofen—Mental disorder—Epirubicin—pancreatic cancer	0.000373	0.000525	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—HES1—pancreatic cancer	0.00037	0.00133	CbGpPWpGaD
Baclofen—Malnutrition—Epirubicin—pancreatic cancer	0.00037	0.000522	CcSEcCtD
Baclofen—Feeling abnormal—Docetaxel—pancreatic cancer	0.000369	0.00052	CcSEcCtD
Baclofen—Nausea—Fluorouracil—pancreatic cancer	0.000369	0.00052	CcSEcCtD
Baclofen—Eye disorder—Doxorubicin—pancreatic cancer	0.000368	0.000518	CcSEcCtD
Baclofen—Tinnitus—Doxorubicin—pancreatic cancer	0.000367	0.000517	CcSEcCtD
Baclofen—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000366	0.000516	CcSEcCtD
Baclofen—Flushing—Doxorubicin—pancreatic cancer	0.000365	0.000515	CcSEcCtD
Baclofen—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000365	0.000515	CcSEcCtD
Baclofen—Flatulence—Epirubicin—pancreatic cancer	0.000365	0.000514	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—PTHLH—pancreatic cancer	0.000364	0.00131	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTCH1—pancreatic cancer	0.000364	0.00131	CbGpPWpGaD
Baclofen—Dysgeusia—Epirubicin—pancreatic cancer	0.000363	0.000511	CcSEcCtD
Baclofen—GABBR1—Neuronal System—HRAS—pancreatic cancer	0.000362	0.0013	CbGpPWpGaD
Baclofen—Back pain—Epirubicin—pancreatic cancer	0.000358	0.000505	CcSEcCtD
Baclofen—Angiopathy—Doxorubicin—pancreatic cancer	0.000357	0.000503	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000355	0.00127	CbGpPWpGaD
Baclofen—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000355	0.0005	CcSEcCtD
Baclofen—Abdominal pain—Docetaxel—pancreatic cancer	0.000354	0.000499	CcSEcCtD
Baclofen—Body temperature increased—Docetaxel—pancreatic cancer	0.000354	0.000499	CcSEcCtD
Baclofen—Chills—Doxorubicin—pancreatic cancer	0.000353	0.000498	CcSEcCtD
Baclofen—Arrhythmia—Doxorubicin—pancreatic cancer	0.000351	0.000495	CcSEcCtD
Baclofen—Vision blurred—Epirubicin—pancreatic cancer	0.000349	0.000492	CcSEcCtD
Baclofen—Alopecia—Doxorubicin—pancreatic cancer	0.000348	0.00049	CcSEcCtD
Baclofen—Mental disorder—Doxorubicin—pancreatic cancer	0.000345	0.000486	CcSEcCtD
Baclofen—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000343	0.000484	CcSEcCtD
Baclofen—Malnutrition—Doxorubicin—pancreatic cancer	0.000343	0.000483	CcSEcCtD
Baclofen—Anaemia—Epirubicin—pancreatic cancer	0.000342	0.000482	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—CXCL8—pancreatic cancer	0.000341	0.00122	CbGpPWpGaD
Baclofen—Agitation—Epirubicin—pancreatic cancer	0.00034	0.000479	CcSEcCtD
Baclofen—Flatulence—Doxorubicin—pancreatic cancer	0.000338	0.000476	CcSEcCtD
Baclofen—Dysgeusia—Doxorubicin—pancreatic cancer	0.000335	0.000473	CcSEcCtD
Baclofen—Malaise—Epirubicin—pancreatic cancer	0.000334	0.000471	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—SST—pancreatic cancer	0.000333	0.00119	CbGpPWpGaD
Baclofen—Vertigo—Epirubicin—pancreatic cancer	0.000333	0.000469	CcSEcCtD
Baclofen—Syncope—Epirubicin—pancreatic cancer	0.000332	0.000468	CcSEcCtD
Baclofen—Back pain—Doxorubicin—pancreatic cancer	0.000331	0.000467	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000328	0.00118	CbGpPWpGaD
Baclofen—Palpitations—Epirubicin—pancreatic cancer	0.000327	0.000461	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—JAG1—pancreatic cancer	0.000326	0.00117	CbGpPWpGaD
Baclofen—Loss of consciousness—Epirubicin—pancreatic cancer	0.000325	0.000459	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—TERT—pancreatic cancer	0.000324	0.00116	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000324	0.00116	CbGpPWpGaD
Baclofen—Vision blurred—Doxorubicin—pancreatic cancer	0.000323	0.000455	CcSEcCtD
Baclofen—Asthenia—Docetaxel—pancreatic cancer	0.000321	0.000453	CcSEcCtD
Baclofen—Convulsion—Epirubicin—pancreatic cancer	0.000321	0.000452	CcSEcCtD
Baclofen—Hypertension—Epirubicin—pancreatic cancer	0.00032	0.00045	CcSEcCtD
Baclofen—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000318	0.000448	CcSEcCtD
Baclofen—Pruritus—Docetaxel—pancreatic cancer	0.000317	0.000447	CcSEcCtD
Baclofen—Anaemia—Doxorubicin—pancreatic cancer	0.000317	0.000446	CcSEcCtD
Baclofen—Chest pain—Epirubicin—pancreatic cancer	0.000315	0.000444	CcSEcCtD
Baclofen—Myalgia—Epirubicin—pancreatic cancer	0.000315	0.000444	CcSEcCtD
Baclofen—Agitation—Doxorubicin—pancreatic cancer	0.000315	0.000444	CcSEcCtD
Baclofen—Anxiety—Epirubicin—pancreatic cancer	0.000314	0.000443	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000313	0.000441	CcSEcCtD
Baclofen—Discomfort—Epirubicin—pancreatic cancer	0.000311	0.000439	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—HIF1A—pancreatic cancer	0.00031	0.00111	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TSC2—pancreatic cancer	0.00031	0.00111	CbGpPWpGaD
Baclofen—Malaise—Doxorubicin—pancreatic cancer	0.000309	0.000435	CcSEcCtD
Baclofen—Dry mouth—Epirubicin—pancreatic cancer	0.000308	0.000434	CcSEcCtD
Baclofen—Vertigo—Doxorubicin—pancreatic cancer	0.000308	0.000434	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CNR1—pancreatic cancer	0.000307	0.0011	CbGpPWpGaD
Baclofen—Syncope—Doxorubicin—pancreatic cancer	0.000307	0.000433	CcSEcCtD
Baclofen—Diarrhoea—Docetaxel—pancreatic cancer	0.000306	0.000432	CcSEcCtD
Baclofen—Confusional state—Epirubicin—pancreatic cancer	0.000305	0.000429	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—APOE—pancreatic cancer	0.000303	0.00109	CbGpPWpGaD
Baclofen—Palpitations—Doxorubicin—pancreatic cancer	0.000303	0.000427	CcSEcCtD
Baclofen—Oedema—Epirubicin—pancreatic cancer	0.000302	0.000426	CcSEcCtD
Baclofen—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000301	0.000424	CcSEcCtD
Baclofen—Infection—Epirubicin—pancreatic cancer	0.0003	0.000423	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000298	0.00107	CbGpPWpGaD
Baclofen—Shock—Epirubicin—pancreatic cancer	0.000297	0.000419	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—GCG—pancreatic cancer	0.000297	0.00106	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KDR—pancreatic cancer	0.000297	0.00106	CbGpPWpGaD
Baclofen—Convulsion—Doxorubicin—pancreatic cancer	0.000297	0.000418	CcSEcCtD
Baclofen—Nervous system disorder—Epirubicin—pancreatic cancer	0.000296	0.000418	CcSEcCtD
Baclofen—Dizziness—Docetaxel—pancreatic cancer	0.000296	0.000417	CcSEcCtD
Baclofen—Hypertension—Doxorubicin—pancreatic cancer	0.000296	0.000417	CcSEcCtD
Baclofen—Tachycardia—Epirubicin—pancreatic cancer	0.000295	0.000416	CcSEcCtD
Baclofen—Skin disorder—Epirubicin—pancreatic cancer	0.000293	0.000414	CcSEcCtD
Baclofen—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000292	0.000412	CcSEcCtD
Baclofen—Chest pain—Doxorubicin—pancreatic cancer	0.000292	0.000411	CcSEcCtD
Baclofen—Myalgia—Doxorubicin—pancreatic cancer	0.000292	0.000411	CcSEcCtD
Baclofen—Anxiety—Doxorubicin—pancreatic cancer	0.000291	0.00041	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00029	0.000408	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000289	0.00104	CbGpPWpGaD
Baclofen—Discomfort—Doxorubicin—pancreatic cancer	0.000288	0.000406	CcSEcCtD
Baclofen—Anorexia—Epirubicin—pancreatic cancer	0.000288	0.000406	CcSEcCtD
Baclofen—Dry mouth—Doxorubicin—pancreatic cancer	0.000285	0.000402	CcSEcCtD
Baclofen—Vomiting—Docetaxel—pancreatic cancer	0.000285	0.000401	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—AGTR1—pancreatic cancer	0.000283	0.00102	CbGpPWpGaD
Baclofen—Rash—Docetaxel—pancreatic cancer	0.000282	0.000398	CcSEcCtD
Baclofen—Hypotension—Epirubicin—pancreatic cancer	0.000282	0.000398	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—NFKBIA—pancreatic cancer	0.000282	0.00101	CbGpPWpGaD
Baclofen—Dermatitis—Docetaxel—pancreatic cancer	0.000282	0.000398	CcSEcCtD
Baclofen—Confusional state—Doxorubicin—pancreatic cancer	0.000282	0.000397	CcSEcCtD
Baclofen—Headache—Docetaxel—pancreatic cancer	0.000281	0.000395	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—NOTCH1—pancreatic cancer	0.00028	0.001	CbGpPWpGaD
Baclofen—Oedema—Doxorubicin—pancreatic cancer	0.00028	0.000394	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—STK11—pancreatic cancer	0.000279	0.001	CbGpPWpGaD
Baclofen—Infection—Doxorubicin—pancreatic cancer	0.000278	0.000391	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000275	0.000388	CcSEcCtD
Baclofen—Shock—Doxorubicin—pancreatic cancer	0.000275	0.000388	CcSEcCtD
Baclofen—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000274	0.000386	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—PIK3CG—pancreatic cancer	0.000273	0.000981	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—NRAS—pancreatic cancer	0.000273	0.000981	CbGpPWpGaD
Baclofen—Insomnia—Epirubicin—pancreatic cancer	0.000273	0.000385	CcSEcCtD
Baclofen—Tachycardia—Doxorubicin—pancreatic cancer	0.000273	0.000385	CcSEcCtD
Baclofen—Skin disorder—Doxorubicin—pancreatic cancer	0.000272	0.000383	CcSEcCtD
Baclofen—Paraesthesia—Epirubicin—pancreatic cancer	0.000271	0.000382	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—EGF—pancreatic cancer	0.00027	0.000969	CbGpPWpGaD
Baclofen—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.00027	0.000381	CcSEcCtD
Baclofen—Dyspnoea—Epirubicin—pancreatic cancer	0.000269	0.00038	CcSEcCtD
Baclofen—Somnolence—Epirubicin—pancreatic cancer	0.000269	0.000379	CcSEcCtD
Baclofen—Anorexia—Doxorubicin—pancreatic cancer	0.000266	0.000376	CcSEcCtD
Baclofen—Nausea—Docetaxel—pancreatic cancer	0.000266	0.000375	CcSEcCtD
Baclofen—Dyspepsia—Epirubicin—pancreatic cancer	0.000266	0.000375	CcSEcCtD
Baclofen—Decreased appetite—Epirubicin—pancreatic cancer	0.000263	0.00037	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000262	0.00094	CbGpPWpGaD
Baclofen—Hypotension—Doxorubicin—pancreatic cancer	0.000261	0.000368	CcSEcCtD
Baclofen—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000261	0.000368	CcSEcCtD
Baclofen—Fatigue—Epirubicin—pancreatic cancer	0.00026	0.000367	CcSEcCtD
Baclofen—Pain—Epirubicin—pancreatic cancer	0.000258	0.000364	CcSEcCtD
Baclofen—Constipation—Epirubicin—pancreatic cancer	0.000258	0.000364	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000255	0.000359	CcSEcCtD
Baclofen—Insomnia—Doxorubicin—pancreatic cancer	0.000253	0.000356	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000252	0.000903	CbGpPWpGaD
Baclofen—Paraesthesia—Doxorubicin—pancreatic cancer	0.000251	0.000354	CcSEcCtD
Baclofen—Dyspnoea—Doxorubicin—pancreatic cancer	0.000249	0.000351	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—EGFR—pancreatic cancer	0.000249	0.000893	CbGpPWpGaD
Baclofen—Feeling abnormal—Epirubicin—pancreatic cancer	0.000249	0.000351	CcSEcCtD
Baclofen—Somnolence—Doxorubicin—pancreatic cancer	0.000249	0.00035	CcSEcCtD
Baclofen—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000247	0.000348	CcSEcCtD
Baclofen—Dyspepsia—Doxorubicin—pancreatic cancer	0.000246	0.000347	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—SMAD4—pancreatic cancer	0.000244	0.000877	CbGpPWpGaD
Baclofen—Decreased appetite—Doxorubicin—pancreatic cancer	0.000243	0.000342	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000242	0.000867	CbGpPWpGaD
Baclofen—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000241	0.00034	CcSEcCtD
Baclofen—Fatigue—Doxorubicin—pancreatic cancer	0.000241	0.00034	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—PIK3CD—pancreatic cancer	0.00024	0.000862	CbGpPWpGaD
Baclofen—Urticaria—Epirubicin—pancreatic cancer	0.00024	0.000338	CcSEcCtD
Baclofen—Constipation—Doxorubicin—pancreatic cancer	0.000239	0.000337	CcSEcCtD
Baclofen—Pain—Doxorubicin—pancreatic cancer	0.000239	0.000337	CcSEcCtD
Baclofen—Body temperature increased—Epirubicin—pancreatic cancer	0.000239	0.000337	CcSEcCtD
Baclofen—Abdominal pain—Epirubicin—pancreatic cancer	0.000239	0.000337	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—HES1—pancreatic cancer	0.000239	0.000856	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000238	0.000854	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—KRAS—pancreatic cancer	0.000235	0.000844	CbGpPWpGaD
Baclofen—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00023	0.000325	CcSEcCtD
Baclofen—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000229	0.000322	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000229	0.00082	CbGpPWpGaD
Baclofen—Urticaria—Doxorubicin—pancreatic cancer	0.000222	0.000313	CcSEcCtD
Baclofen—Body temperature increased—Doxorubicin—pancreatic cancer	0.000221	0.000311	CcSEcCtD
Baclofen—Abdominal pain—Doxorubicin—pancreatic cancer	0.000221	0.000311	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—CXCL8—pancreatic cancer	0.00022	0.000788	CbGpPWpGaD
Baclofen—Asthenia—Epirubicin—pancreatic cancer	0.000217	0.000306	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000216	0.000775	CbGpPWpGaD
Baclofen—Pruritus—Epirubicin—pancreatic cancer	0.000214	0.000301	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—PIK3CB—pancreatic cancer	0.000209	0.000751	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TERT—pancreatic cancer	0.000209	0.00075	CbGpPWpGaD
Baclofen—Diarrhoea—Epirubicin—pancreatic cancer	0.000207	0.000291	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CXCL8—pancreatic cancer	0.000201	0.000722	CbGpPWpGaD
Baclofen—Asthenia—Doxorubicin—pancreatic cancer	0.000201	0.000283	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—HRAS—pancreatic cancer	0.0002	0.000717	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HIF1A—pancreatic cancer	0.0002	0.000717	CbGpPWpGaD
Baclofen—Dizziness—Epirubicin—pancreatic cancer	0.0002	0.000282	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—TSC2—pancreatic cancer	0.000199	0.000715	CbGpPWpGaD
Baclofen—Pruritus—Doxorubicin—pancreatic cancer	0.000198	0.000279	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—APOE—pancreatic cancer	0.000195	0.0007	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—AKT1—pancreatic cancer	0.000194	0.000698	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CASP3—pancreatic cancer	0.000193	0.000691	CbGpPWpGaD
Baclofen—Vomiting—Epirubicin—pancreatic cancer	0.000192	0.000271	CcSEcCtD
Baclofen—Diarrhoea—Doxorubicin—pancreatic cancer	0.000191	0.00027	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—KDR—pancreatic cancer	0.000191	0.000686	CbGpPWpGaD
Baclofen—Rash—Epirubicin—pancreatic cancer	0.00019	0.000268	CcSEcCtD
Baclofen—Dermatitis—Epirubicin—pancreatic cancer	0.00019	0.000268	CcSEcCtD
Baclofen—Headache—Epirubicin—pancreatic cancer	0.000189	0.000267	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CCND1—pancreatic cancer	0.000188	0.000673	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CTNNB1—pancreatic cancer	0.000186	0.000666	CbGpPWpGaD
Baclofen—Dizziness—Doxorubicin—pancreatic cancer	0.000185	0.000261	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—MMP9—pancreatic cancer	0.000182	0.000653	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NFKBIA—pancreatic cancer	0.000182	0.000652	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PTEN—pancreatic cancer	0.000181	0.000649	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NOTCH1—pancreatic cancer	0.00018	0.000646	CbGpPWpGaD
Baclofen—Nausea—Epirubicin—pancreatic cancer	0.000179	0.000253	CcSEcCtD
Baclofen—Vomiting—Doxorubicin—pancreatic cancer	0.000178	0.000251	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—AKT1—pancreatic cancer	0.000177	0.000633	CbGpPWpGaD
Baclofen—Rash—Doxorubicin—pancreatic cancer	0.000176	0.000248	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—PIK3CG—pancreatic cancer	0.000176	0.000632	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—NRAS—pancreatic cancer	0.000176	0.000632	CbGpPWpGaD
Baclofen—Dermatitis—Doxorubicin—pancreatic cancer	0.000176	0.000248	CcSEcCtD
Baclofen—Headache—Doxorubicin—pancreatic cancer	0.000175	0.000247	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—EGF—pancreatic cancer	0.000174	0.000625	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SRC—pancreatic cancer	0.000168	0.000602	CbGpPWpGaD
Baclofen—Nausea—Doxorubicin—pancreatic cancer	0.000166	0.000234	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—VEGFA—pancreatic cancer	0.000164	0.000586	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—STAT3—pancreatic cancer	0.000162	0.000581	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NRAS—pancreatic cancer	0.000162	0.000579	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—EGFR—pancreatic cancer	0.000161	0.000576	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CD—pancreatic cancer	0.000155	0.000555	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000153	0.00055	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—KRAS—pancreatic cancer	0.000152	0.000544	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MYC—pancreatic cancer	0.00015	0.00054	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TGFB1—pancreatic cancer	0.00015	0.000538	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—EGFR—pancreatic cancer	0.000147	0.000528	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000139	0.0005	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KRAS—pancreatic cancer	0.000139	0.000499	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CB—pancreatic cancer	0.000135	0.000484	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CXCL8—pancreatic cancer	0.00013	0.000465	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—HRAS—pancreatic cancer	0.000129	0.000462	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CA—pancreatic cancer	0.000128	0.000458	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—AKT1—pancreatic cancer	0.000125	0.000449	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CASP3—pancreatic cancer	0.000124	0.000445	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TP53—pancreatic cancer	0.000124	0.000443	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCND1—pancreatic cancer	0.000121	0.000433	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CTNNB1—pancreatic cancer	0.00012	0.000429	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HRAS—pancreatic cancer	0.000118	0.000424	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MMP9—pancreatic cancer	0.000117	0.000421	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTEN—pancreatic cancer	0.000117	0.000418	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—AKT1—pancreatic cancer	0.000114	0.000408	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SRC—pancreatic cancer	0.000108	0.000388	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—VEGFA—pancreatic cancer	0.000105	0.000378	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—STAT3—pancreatic cancer	0.000104	0.000374	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AKT1—pancreatic cancer	0.000104	0.000374	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NRAS—pancreatic cancer	0.000104	0.000373	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MYC—pancreatic cancer	9.69e-05	0.000348	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TGFB1—pancreatic cancer	9.67e-05	0.000347	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EGFR—pancreatic cancer	9.48e-05	0.00034	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KRAS—pancreatic cancer	8.96e-05	0.000321	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CA—pancreatic cancer	8.23e-05	0.000295	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TP53—pancreatic cancer	7.96e-05	0.000286	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HRAS—pancreatic cancer	7.61e-05	0.000273	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AKT1—pancreatic cancer	6.72e-05	0.000241	CbGpPWpGaD
